RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use

YY Syed - Drugs & Therapy Perspectives, 2022 - Springer
RTS,S/AS01 vaccine efficacy against the first and only … clinically relevant protection was
still evident 18 months after the … since the first vaccination in children aged 5–17 months) [18]. …

Towards eradication of malaria: is the WHO's RTS, S/AS01 vaccination effective enough?

N Arora, LC Anbalagan, AK Pannu - Risk Management and …, 2021 - Taylor & Francis
… In conclusion, the protective efficacy of RTS,S/AS01 malaria vaccine is affected by multiple
… –17 months and at 1-month intervals, followed by a fourth booster dose 18 months after the …

RTS, S/AS01 vaccine (Mosquirix™): an overview

MB Laurens - Human vaccines & immunotherapeutics, 2020 - Taylor & Francis
… , including a booster given 18 months after the first dose. … and seasonal malaria
chemoprophylaxis, RTS,S/AS01 vaccination … increase vaccine efficacy and overall benefit of …

Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Y Guerra Mendoza, E Garric, A Leach… - Human vaccines & …, 2019 - Taylor & Francis
vaccine, consistent with the time window of post-vaccination … -up periods from dose 1 up to
12 months or 18 months post-… 4-dose regimen of RTS,S/AS01 was efficacious and provided …

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: a review

H Mumtaz, A Nadeem, W Bilal, F Ansar… - Immunity …, 2023 - Wiley Online Library
… fourth dose 15 to 18 months after the third dose. The first dose should be given as close to 5
… children aged 5–17 months. The low efficacy of the RTS, S/AS01 vaccination in babies was …

RTS, S/AS01 malaria vaccine—proven safe and effective?

A Björkman, CS Benn, P Aaby… - The Lancet Infectious …, 2023 - thelancet.com
Efficacy and safety of RTS,S/AS01 malaria vaccine with or … per country enrolled during 30
months of vaccination and a total … months to 18 months of age on average (range 1–30 months)…

Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 …

H Tinto, W Otieno, S Gesase, H Sorgho… - The Lancet Infectious …, 2019 - thelancet.com
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants
and children in Africa: final results of a phase 3, individually randomised, controlled trial. …

Mosquirix™ RTS, S/AS01 vaccine development, immunogenicity, and efficacy

AY Nadeem, A Shehzad, SU Islam, EA Al-Suhaimi… - Vaccines, 2022 - mdpi.com
RTS, S/AS01 is administered via intramuscular injection as a lyophilized suspension. Children
are … After that, children aged 15–18 months should be given a fourth shot of vaccination. …

[HTML][HTML] Safety and immunogenicity of the RTS, S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan …

L Otieno, YG Mendoza, S Adjei, T Agbenyega… - Vaccine, 2020 - Elsevier
… Here, we report results of RTS,S/AS01 vaccination in a small … Previous findings from our large
phase III efficacy trial … included the safety of a fourth dose given 18 months after dose 3 and …

A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS, S/AS01E in a controlled human malaria infection challenge

…, RTS S Malaria Vaccine Working Group - Vaccine, 2021 - Elsevier
… that RTS,S/AS01 B and RTS,S/AS01 E vaccination regimens … one month intervals and a
booster dose at 18 months after the … from the European Medicines Agency on its safety, efficacy